Major Pharma Companies Harness Apheris for AI Drug Discovery
Discover how major pharmaceutical companies are using the Apheris Compute Gateway to revolutionize AI-driven drug discovery and accelerate innovation.
Topic
Pharmaceutical
A collection of 10 issues
Drug Fails to Show Significant Improvement in Depression
The recent trial of a new drug for depression did not achieve statistically significant results in improving symptoms. Stay informed on mental health treatments.
Pharma Giants Pivot to Cancer Therapies
Discover how pharmaceutical companies are focusing on core businesses to drive growth in cancer therapies, reshaping the industry's future.
Eli Lilly's Zepbound Achieves Remarkable 24% Weight Loss
Discover how Eli Lilly's weight-loss drug, Zepbound, delivers up to 24% weight loss, securing its competitive edge in the pharmaceutical market.
Novo Nordisk Shares Fall on CagriSema Trial Setback
Novo Nordisk's stock experienced a decline following underwhelming results from the CagriSema trial, impacting investor sentiment. Stay updated with the latest insights.
Drugmakers to Hike U.S. Prices on 250+ Medications in 2025
Pharmaceutical companies plan to increase U.S. prices on over 250 branded drugs starting in 2025, impacting healthcare costs and patient spending.
Roche's Anti-Obesity Drug May Launch by 2029
Roche is developing a promising anti-obesity drug, potentially hitting the market by 2029. Stay updated on this exciting advancement in weight management solutions.
Veeva Dominates Pharma CRM Market with 80% Share
Explore how Veeva holds over 80% market share in pharmaceutical CRM software, cementing its leadership in the industry.
Salesforce Challenges Veeva in Pharma CRM Market
Salesforce Inc. is intensifying its competition with Veeva Systems Inc. to capture a significant share of the pharmaceutical CRM software market.
Salesforce Secures Over 40 Deals for New Life Sciences Product
Salesforce lands over 40 customer deals, including a leading global pharma company, for its upcoming life sciences product, signaling growth in the sector.